DK0934061T6
(en)
|
1996-07-24 |
2015-01-26 |
Warner Lambert Co |
Isobutylgaba and its derivatives for the treatment of pain
|
US6464986B1
(en)
*
|
2000-04-14 |
2002-10-15 |
Allegan Sales, Inc. |
Method for treating pain by peripheral administration of a neurotoxin
|
US7074961B2
(en)
|
2000-09-26 |
2006-07-11 |
The Brigham And Women's Hospital, Inc. |
Antidepressants and their analogues as long-acting local anesthetics and analgesics
|
US6545057B2
(en)
*
|
2000-09-26 |
2003-04-08 |
The Brigham And Women's Hospital Inc. |
Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics
|
CZ20032814A3
(cs)
*
|
2001-04-20 |
2004-08-18 |
Pfizeráproductsáinc |
Způsob přípravy �Ź@@substituovaných indenů a aryl@kondezovaných azapolycyklických sloučenin
|
CA2449987C
(en)
*
|
2001-06-07 |
2015-11-03 |
Christine N. Sang |
Treatment of central neuropathic pain
|
AR036040A1
(es)
|
2001-06-12 |
2004-08-04 |
Upjohn Co |
Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
|
SE521512C2
(sv)
|
2001-06-25 |
2003-11-11 |
Niconovum Ab |
Anordning för administrering av en substans till främre delen av en individs munhåla
|
US20040138239A1
(en)
*
|
2001-08-23 |
2004-07-15 |
Bruce Frome |
Compositions and methods for targeting cerebral circulation and treatment of headache
|
CA2458375A1
(en)
|
2001-08-24 |
2003-03-06 |
Pharmacia & Upjohn Company |
Substituted-heteroaryl-7-aza¬2.2.1|bicycloheptanes for the treatment of disease
|
HUP0402289A2
(hu)
|
2001-10-02 |
2005-02-28 |
Pharmacia & Upjohn Company |
Gyógyhatású azabiciklusos csoporttal helyettesített kondenzált heteroaril-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
|
US7612112B2
(en)
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
US6849620B2
(en)
|
2001-10-26 |
2005-02-01 |
Pfizer Inc |
N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
|
US6602911B2
(en)
*
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
MXPA04004373A
(es)
|
2001-11-09 |
2004-08-11 |
Upjohn Co |
Compuestos heterociclicos condensados con fenilo azabiciclo para el tratamiento de enfermedades.
|
AU2002366588A1
(en)
*
|
2001-12-13 |
2003-06-23 |
Council Of Scientific And Industrial Research |
Bioavailability enhancing activity of zingiber officinale linn and its extracts/fractions thereof
|
EP1471910A2
(en)
*
|
2002-01-17 |
2004-11-03 |
Neurogen Corporation |
Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
|
AU2003207219A1
(en)
|
2002-02-05 |
2003-09-02 |
Ajinomoto Co., Inc. |
Medicinal compositions containing gabapentin or pregabalin and n-type calcium channel antagonist
|
AU2003213009A1
(en)
*
|
2002-02-12 |
2003-09-04 |
Cypress Bioscience, Inc. |
Methods of treating attention deficit/hyperactivity disorder (adhd)
|
JP2005522456A
(ja)
|
2002-02-15 |
2005-07-28 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
Cns関連障害治療のためのアザビシクロ置換ベンゾイルアミドおよびチオアミド
|
US6858613B2
(en)
|
2002-02-19 |
2005-02-22 |
Pfizer Inc. |
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
|
EP1476448A2
(en)
|
2002-02-19 |
2004-11-17 |
PHARMACIA & UPJOHN COMPANY |
Azabicyclic compounds for the treatment of disease
|
AU2003225206B2
(en)
*
|
2002-04-24 |
2008-02-14 |
Forest Laboratories Holdings Limited |
Prevention and treatment of functional somatic disorders, including stress-related disorders
|
US6921538B2
(en)
*
|
2002-05-10 |
2005-07-26 |
Allergan, Inc. |
Therapeutic treatments for neuropsychiatric disorders
|
US20040014681A1
(en)
*
|
2002-05-14 |
2004-01-22 |
Ralph Ryback |
Method for treating dermatoses and tissue damage
|
WO2003097043A1
(en)
*
|
2002-05-15 |
2003-11-27 |
Abbott Laboratories |
Treatment of neuropathic pain
|
CN100469776C
(zh)
|
2002-05-17 |
2009-03-18 |
奥特拉控股公司 |
白内障和其它眼病发展的改善
|
EP1553934A1
(en)
*
|
2002-10-17 |
2005-07-20 |
Novartis AG |
Pharmaceutical composition for treating pain comprising oxicarbazepine, or derivatives thereof, and cox2 inhibitors
|
ATE547424T1
(de)
|
2002-12-02 |
2012-03-15 |
Xenome Ltd |
Chi-conotoxinpeptide mit einer n-terminalen pyroglutaminsäure
|
WO2004050688A1
(en)
|
2002-12-02 |
2004-06-17 |
Xenome Ltd |
NOVEL χ-CONOTOXIN PEPTIDES (-II)
|
US20040204411A1
(en)
*
|
2002-12-17 |
2004-10-14 |
Pharmacia Corporation |
Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof
|
EP3473251B1
(en)
|
2002-12-20 |
2023-12-13 |
NicoNovum AB |
A nicotine-cellulose combination
|
ATE538807T1
(de)
*
|
2003-03-06 |
2012-01-15 |
Botulinum Toxin Res Associates Inc |
Behandlung von sinusitis-assoziierten beschwerden mit botulinum toxin
|
EA008705B1
(ru)
*
|
2003-04-08 |
2007-06-29 |
Алгоркс Фармасьютикалз, Инк. |
Получение и очистка синтетического капсаицина
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
WO2004105690A2
(en)
*
|
2003-05-23 |
2004-12-09 |
Cypress Bioscience, Inc. |
Treatment of chronic pain associated with drug or radiation therapy
|
US8030300B2
(en)
|
2003-06-10 |
2011-10-04 |
Georgetown University |
Ligands for nicotinic acetylcholine receptors, and methods of making and using them
|
US20050004219A1
(en)
*
|
2003-07-01 |
2005-01-06 |
Medtronic, Inc. |
Pump systems including injectable gabapentin compositions
|
US20050004221A1
(en)
*
|
2003-07-01 |
2005-01-06 |
Medtronic, Inc. |
Intrathecal gabapentin compositions
|
US20050043406A1
(en)
*
|
2003-08-22 |
2005-02-24 |
Pfizer Inc |
Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
|
US20050043407A1
(en)
*
|
2003-08-22 |
2005-02-24 |
Pfizer Inc |
Pharmaceutical composition for the prevention and treatment of addiction in a mammal
|
US20050058696A1
(en)
*
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
EP1689401A1
(en)
|
2003-10-02 |
2006-08-16 |
Elan Pharmaceuticals, Inc. |
Method for reducing pain
|
US20050090549A1
(en)
*
|
2003-10-23 |
2005-04-28 |
Medtronic, Inc. |
Intrathecal gabapentin for treatment of pain
|
US20050090548A1
(en)
*
|
2003-10-23 |
2005-04-28 |
Medtronic, Inc. |
Intrathecal gabapentin for treatment of epilepsy
|
CA2543315A1
(en)
*
|
2003-11-13 |
2005-06-02 |
The General Hospital Corporation |
Methods for treating pain
|
US8871224B2
(en)
|
2003-12-09 |
2014-10-28 |
Allergan, Inc. |
Botulinum toxin therapy for skin disorders
|
HU230403B1
(hu)
*
|
2003-12-19 |
2016-04-28 |
Pál Kocsis |
Nátrium csatorna blokkoló és szerotonin újrafelvétel gátló tartalmú gyógyszerkészítmény
|
US20100266638A1
(en)
*
|
2004-02-26 |
2010-10-21 |
Allergan, Inc. |
Headache treatment method
|
US20050220734A1
(en)
*
|
2004-04-02 |
2005-10-06 |
Allergan, Inc. |
Therapy for melanin related afflictions
|
WO2005123043A2
(en)
*
|
2004-06-10 |
2005-12-29 |
Duramed Pharmaceuticals, Inc. |
Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
|
MY147767A
(en)
|
2004-06-16 |
2013-01-31 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
AU2005299748B2
(en)
*
|
2004-10-21 |
2009-04-09 |
Tgel Bio Co., Ltd |
In situ controlled release drug delivery system
|
WO2006053012A2
(en)
*
|
2004-11-10 |
2006-05-18 |
Trinity Laboratories, Inc. |
Novel pharmaceutical compositions for treating acquired chronic pain and associated dysphoria
|
BRPI0516912A2
(pt)
*
|
2004-11-24 |
2009-06-23 |
Algorx Pharmaceuticals Inc |
formulação a base do capsaicinoide em gel e usos da mesma
|
US20060252745A1
(en)
|
2005-05-06 |
2006-11-09 |
Almeida Jose L D |
Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
|
AU2006249577A1
(en)
|
2005-05-20 |
2006-11-30 |
Janssen Pharmaceutica N.V. |
Process for preparation of sulfamide derivatives
|
US7994220B2
(en)
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
US8937096B2
(en)
|
2005-12-19 |
2015-01-20 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
|
US8716231B2
(en)
|
2005-12-19 |
2014-05-06 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
|
US8497298B2
(en)
|
2005-12-19 |
2013-07-30 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
|
US8492431B2
(en)
|
2005-12-19 |
2013-07-23 |
Janssen Pharmaceutica, N.V. |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
|
US8691867B2
(en)
|
2005-12-19 |
2014-04-08 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
|
US20090176882A1
(en)
*
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
GB0603008D0
(en)
*
|
2006-02-14 |
2006-03-29 |
Portela & Ca Sa |
Method
|
WO2007104573A2
(en)
|
2006-03-16 |
2007-09-20 |
Niconovum Ab |
Improved snuff composition
|
JP2007308403A
(ja)
*
|
2006-05-17 |
2007-11-29 |
Kenji Yoshida |
皮膚外用剤
|
EP2026790A2
(en)
|
2006-05-19 |
2009-02-25 |
Janssen Pharmaceutica, N.V. |
Co-therapy for the treatment of epilepsy and related disorders
|
CN101074935B
(zh)
*
|
2006-05-19 |
2011-03-23 |
清华大学 |
探测器阵列及设备
|
FR2902341B1
(fr)
|
2006-06-16 |
2011-02-25 |
Scras |
Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
|
KR20090048462A
(ko)
*
|
2006-07-17 |
2009-05-13 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
통증완화용 gaba 접합체
|
JPWO2008020651A1
(ja)
*
|
2006-08-17 |
2010-01-07 |
国立大学法人九州大学 |
P2x4受容体アンタゴニスト
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
US7645767B2
(en)
*
|
2006-08-31 |
2010-01-12 |
Trinity Laboratories, Inc. |
Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
|
WO2008036858A2
(en)
*
|
2006-09-20 |
2008-03-27 |
The Board Of Regents Of The University Of Texas System |
Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
|
WO2008073381A2
(en)
*
|
2006-12-11 |
2008-06-19 |
University Of Kentucky Research Foundation |
Synergistic effects of combinations of nornicotine and opioids for the treatment of pain
|
FR2910327B1
(fr)
|
2006-12-22 |
2013-04-26 |
Scras |
Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
|
GB0700773D0
(en)
|
2007-01-15 |
2007-02-21 |
Portela & Ca Sa |
Drug therapies
|
CA2698808A1
(en)
|
2007-09-13 |
2009-03-19 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
|
WO2009095877A2
(en)
*
|
2008-01-31 |
2009-08-06 |
Fund For Medical Research Development Of Infrastructure And Health Services Rambam Medical Center |
Method of predicting pain medication efficacy
|
FR2930447B1
(fr)
|
2008-04-25 |
2010-07-30 |
Sod Conseils Rech Applic |
Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique
|
CN102014625A
(zh)
|
2008-04-28 |
2011-04-13 |
佐吉尼克斯股份有限公司 |
用于治疗偏头痛的新制剂
|
BRPI0915890A2
(pt)
|
2008-06-23 |
2015-11-03 |
Janssen Pharmaceutica Nv |
forma cristalina de (2s)-(-)-n-(6-cloro-2,3-di-hidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
|
US8815939B2
(en)
|
2008-07-22 |
2014-08-26 |
Janssen Pharmaceutica Nv |
Substituted sulfamide derivatives
|
US20100184685A1
(en)
*
|
2009-01-19 |
2010-07-22 |
Zavala Jr Gerardo |
Systems and methods for treating post- operative, acute, and chronic pain using an intra-muscular catheter administrated combination of a local anesthetic and a neurotoxin protein
|
US8846765B2
(en)
|
2010-06-15 |
2014-09-30 |
Gruenenthal Gmbh |
Pharmaceutical combination
|
WO2012038963A1
(en)
|
2010-09-22 |
2012-03-29 |
Ramot At Tel-Aviv University Ltd. |
An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same
|
PL2826467T3
(pl)
|
2010-12-22 |
2018-01-31 |
Purdue Pharma Lp |
Zamknięte, zabezpieczone przed manipulowaniem formy dozowania o kontrolowanym uwalnianiu
|
ES2581323T3
(es)
|
2010-12-23 |
2016-09-05 |
Purdue Pharma Lp |
Formas de dosificación oral sólida resistentes a alteraciones
|
AU2012218094A1
(en)
*
|
2011-02-18 |
2013-08-29 |
Nestec S.A. |
Methods and compositions for treating, reducing, or preventing damage to the nervous system of animals
|
ES2387973B1
(es)
*
|
2011-03-18 |
2013-10-01 |
Dr Healthcare España, S. L. |
Composiciones tópicas que contienen diaminooxidasa para el tratamiento o la prevención de enfermedades asociadas a un nivel de histamina elevada que comportan un aumento del dolor.
|
US8580850B2
(en)
|
2011-08-11 |
2013-11-12 |
Xenoport, Inc. |
Anhydrous and hemihydrate crystalline forms of an (R)-baclofen prodrug, methods of synthesis and methods of use
|
EA201590381A1
(ru)
*
|
2012-08-16 |
2015-07-30 |
Янссен Фармацевтика Нв |
Замещенные пиразолы, используемые в качестве блокаторов кальциевых каналов n-типа
|
US8652527B1
(en)
|
2013-03-13 |
2014-02-18 |
Upsher-Smith Laboratories, Inc |
Extended-release topiramate capsules
|
US9101545B2
(en)
|
2013-03-15 |
2015-08-11 |
Upsher-Smith Laboratories, Inc. |
Extended-release topiramate capsules
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
WO2015023675A2
(en)
|
2013-08-12 |
2015-02-19 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded immediate release abuse deterrent pill
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|
US10172797B2
(en)
|
2013-12-17 |
2019-01-08 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
US9492444B2
(en)
|
2013-12-17 |
2016-11-15 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
CA2955229C
(en)
|
2014-07-17 |
2020-03-10 |
Pharmaceutical Manufacturing Research Services, Inc. |
Immediate release abuse deterrent liquid fill dosage form
|
JP2017531026A
(ja)
|
2014-10-20 |
2017-10-19 |
ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド |
徐放性乱用抑止性液体充填剤形
|
CN104758933A
(zh)
*
|
2014-10-29 |
2015-07-08 |
吴鑫欣 |
治疗神经卡压、神经瘤疼痛的药物和给药系统
|
US20200023044A1
(en)
*
|
2017-03-22 |
2020-01-23 |
Bonti, Inc. |
Botulinum neurotoxins for treating traumatic injuries
|
WO2018183320A1
(en)
*
|
2017-03-31 |
2018-10-04 |
Depco, Inc. |
Therapeutic putty having analgesics and/or counterirritants
|
CA3059435A1
(en)
*
|
2017-04-12 |
2018-10-18 |
Synergistic Therapeutics, Llc |
Therapeutic neuropathic pain lotion
|
KR101944113B1
(ko)
|
2017-09-28 |
2019-01-30 |
동의대학교 산학협력단 |
급성 안면통증 예방 및 개선용 조성물
|
KR102156438B1
(ko)
|
2018-12-20 |
2020-09-16 |
동의대학교 산학협력단 |
급성 안면통증 예방 및 개선용 조성물
|
KR102156627B1
(ko)
|
2018-12-20 |
2020-09-16 |
동의대학교 산학협력단 |
보스웰리아 추출물 및 산자나무 추출물을 포함하는 급성 안면통증 예방 및 개선용 조성물
|
CN115054601B
(zh)
*
|
2022-03-21 |
2024-04-26 |
中山大学附属第三医院 |
一种可注射的缓释镇痛复合物及其制备方法、应用
|